Ovid Therapeutics (OVID) Non-Current Debt (2019 - 2020)

Ovid Therapeutics (OVID) reported Non-Current Debt of $61200.0 for Q4 2020, down 78.64% on a YoY basis from $286562.0 in Q1 2020, and little changed quarter-over-quarter from $61200.0 in Q3 2020.

Ovid Therapeutics (OVID) Non-Current Debt (2019 - 2020) Analysis & Trends

Ovid Therapeutics has reported Non-Current Debt for 2 years, with the latest figure at $61200.0 in Q4 2020.

  • For the quarter ending Q4 2020, Non-Current Debt fell 78.64% year-over-year to $61200.0; the trailing twelve-month figure through Dec 2020 stood at $61200.0 (down 78.64% YoY), and the FY2020 full-year result was $61200.0, down 78.64% from the prior year.
  • Non-Current Debt for Q4 2020 stood at $61200.0, roughly flat from $61200.0 in the prior quarter.
  • The five-year high for Non-Current Debt was $1.3 million in Q1 2019, with the low at $61200.0 in Q3 2020.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 319.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Ovid Therapeutics 311.83 Mn 156.31 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2020 61,200.00
Dec 31, 2020 61,200.00
Sep 30, 2020 61,200.00
Sep 30, 2020 61,200.00
Jun 30, 2020 286,562.00
Jun 30, 2020 286,562.00
Mar 31, 2020 286,562.00
Mar 31, 2020 286,562.00
Dec 31, 2019 286,562.00
Dec 31, 2019 286,562.00
Sep 30, 2019 286,562.00
Sep 30, 2019 286,562.00
Jun 30, 2019 286,562.00
Jun 30, 2019 286,562.00
Mar 31, 2019 1.34 Mn
Mar 31, 2019 1.34 Mn